PRKAB1 and neoplasm: It is known that mitogen-activated protein kinases (MAP4K1 and MAP4K4) and the insulin resistance pathway (PRKCD and PRKAB1) may be associated with tumor progression through modulation of gene expression responsible for cell cycle, proliferation, and growth [150].